A practical guide to the differential diagnosis of tremor

Postgraduate Medical Journal

Volumn 87, Issue 1031, 2011, Pages 623-629

  Alty, Jane E ^a   Kempster, Peter A ^b  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMIODARONE; AMPHETAMINE; ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CAFFEINE; CANNABIS; CINNARIZINE; COCAINE; FLUNARIZINE; FLUPENTIXOL; HALOPERIDOL; LITHIUM; METOCLOPRAMIDE; NEUROLEPTIC AGENT; OLANZAPINE; PROCHLORPERAZINE; QUETIAPINE; RISPERIDONE; TETRABENAZINE; THEOPHYLLINE; THYROXINE; VALPROIC ACID;

BODY POSTURE; CEREBELLAR TREMOR; CLINICAL EXAMINATION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DYSTONIA; DYSTONIC TREMOR; ESSENTIAL TREMOR; FRAGILE X ASSOCIATED TREMOR ATAXIA SYNDROME; HOLMES TREMOR; HUMAN; MEDICAL HISTORY; METABOLIC TREMOR; NEUROPATHIC TREMOR; ORTHOSTATIC TREMOR; PARKINSON DISEASE; PSYCHOGENIC TREMOR; REST; REVIEW; TREMOR; WILSON DISEASE;

ATAXIA; DIAGNOSIS, DIFFERENTIAL; ESSENTIAL TREMOR; HEPATOLENTICULAR DEGENERATION; HUMANS; MOVEMENT; PARKINSON DISEASE; PARKINSONIAN DISORDERS; PHYSICAL EXAMINATION; POSTURE; PSYCHOPHYSIOLOGIC DISORDERS; REST; TREMOR;

EID: 80052044745     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/pgmj.2009.089623     Document Type: Review

References (48)

1. Bain PG, Findley LJ, Thompson PD, et al. A study of hereditary essential tremor. Brain 1994;117:805-24.
2. Whaley NR, Putze JD, Baba Y, et al. Essential tremor: phenotypic expression in a clinical cohort. Parkinsonism Relat Disord 2007;13:333-9.
3. Tallón-Barranco A, Vázquez A, Javier Jiménez-Jiménez F, et al. Clinical features of essential tremor seen in neurology practice: a study of 357 patients. Parkinsonism Relat Disord 1997;34:187-90.
4. Sulica L, Louis ED. Clinical characteristics of essential voice tremor: a study of 34 cases. Laryngoscope 2010;120:516-28.
5. Louis ED, Ferreira JJ. How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor. Mov Disord 2010;25:534-41.
6. Rajput AH, Offord KP, Beard CM, et al. Essential tremor in Rochester, Minnesota: a 45-year study. J Neurol Neurosurg Psychiatry 1984;47:466-70.
7. Benito-León J, Bermejo-Pareja F, Louis ED; Neurological Disorders in Central Spain (NEDICES) Study Group. Incidence of essential tremor in three elderly populations of central Spain. Neurology 2005;64:1721-5.
8. Deng H, Le W, Jankovic J. Genetics of essential tremor. Brain 2007;130:1456-64.
9. Phibb F, Fang JY, Cooper MK, et al. Prevalence of unilateral tremor in autosomal dominant essential tremor. Mov Disord 2009;24:108-11.
10. Hess CW, Saunders-Pullman R. Movement disorders and alcohol misuse. Addict Biol 2006;11:117-25.
11. Schrag A, Ben-Shlomo Y, Quinn NP. Cross-sectional prevalence study of idiopathic Parkinson's disease and parkinsonism in London. BMJ 2000;321:21-2.
12. Hobson P, Gallacher J, Meara J. Cross-sectional survey of Parkinson's disease and parkinsonism in a rural area of the United Kingdom. Mov Disord 2005;20:995-8.
13. Porter B, Macfarlane R, Unwin N, et al. The prevalence of Parkinson's disease in an area of North Tyneside in the North-East of England. Neuroepidemiology 2006;26:156-61.
14. Hughes AJ, Daniel SE, Blankson S, et al. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993;50:140-8.
15. Hellman MA, Melamed E, Steinmetz AP, et al. Unilateral lower limb rest tremor is not necessarily a presenting symptom of Parkinson's disease. Mov Disord 2010;25:924-7.
16. Josephs KA, Matsumoto JY, Ahlskog E. Benign tremulous parkinsonism. Arch Neurol 2006;63:354-7.
17. Williams DR, De Silva R, Paviour DC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 2005;128:1247-58.
18. Tison F, Yekhlef F, Chrysostome V, et al. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease. Mov Disord 2002;17:701-9.
19. Thavani B, Treadwell S. Drug induced parkinsonism: a common cause of parkinsonism in older people. Postgrad Med J 2009;85:322-6.
20. Morgan JC, Sethi KD. Drug-induced tremors. Lancet Neurology 2005;4:866-76.
21. Karas BJ, Wilder BJ, Hammond EJ, et al. Valproate tremors. Neurology 1982;32:428-32.
22. Gelenberg AJ, Jefferson JW. Lithium Tremor. J Clin Psychiatry 1995;56:283-7.
23. Esper CD, Factor SA. Failure of recognition of drug-induced parkinsonism in the elderly. Mov Disord 2008;23:401-4.
24. Satterthwaite TD, Wolf DH, Rosenheck RA, et al. A meta-analysis of the risk of acute extrapyramidal symptoms with intramuscular antipsychotics for the treatment of agitation. J Clin Psychiatry 2008;69:1869-79.
25. Caligiuri MR, Jeste DV, Lacro JP. Antipsychotic-induced movement disorders in the elderly:epidemiology and treatment recommendations. Drugs Aging 2000;17:363-84.
26. Avorn J, Gerwitz JH, Bohn RL, et al. Increased incidence of levodopa therapy following metoclopramide use. JAMA 1995;274:1780-2.
27. Kenney C, Hunter C, Jankovic J. Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders. Mov Disord 2007;22:193-7.
28. Negrotti A, Calzetti S. A long-term follow-up study of cinnarizine-and flunnarizineinduced parkinsonism. Mov Disord 1997;12:107-10.
29. Bhatia KP, Schneider SA. Psychogenic tremor and related disorders. J Neurol 2007;254:569-74.
30. McAuly J, Rothwell J. Identification of psychogenic, dystonic, and other organic tremors by a coherence entrainment test. Mov Disord 2004;19:253-67.
31. Criswell S, Sterling C, Swisher L, et al. Sensitivity and specificity of the finger tapping test for the detection of psychogenic movement disorders. Parkinsonism Relat Disord 2010;16:197-201.
32. Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord 1998;13(Suppl 3):2-23.
33. Jedynak CP, Bonnet AM, Agid Y. Tremor and idiopathic dystonia. Mov Disord 1991;6:230-6.
34. Svetel M, Ivanovic N, Marinkovic J, et al. Characteristics of dystonic movements in primary and symptomatic dystonias. J Neurol Neurosurg Psychiatry 2004;75:329-30.
35. Schneider SA, Edwards MJ, Mir P, et al. Patients with adult-onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs). Mov Disord 2007;22:2210-15.
36. Quinn NP, Schneider SA, Schwingenschuh P, et al. Tremordsome controversial aspects. Mov Disord 2011;26:18-23.
37. Masuhr F, Wissel J, Muller J, et al. Quantification of sensory trick impact on tremor amplitude and frequency in 60 patients with head tremor. Mov Disord 2000;16:960-4.
38. Milanov I. Clinical and electromyographic examinations of patients with midbrain and cerebellar tremor. Electromyogr Clin Neurophysiol 2002;42:105-12.
39. Kung AW. Neuromuscular complications of thyrotoxicosis. Clin Endocrinol (Oxf) 2007;67:645-50.
40. Milanov I, Sheinkova G. Clinical and electromyographic examination of tremor in patients with thyrotoxicosis. Int J Clin Pract 2000;54:364-7.
41. Bain PG, Britton TC, Jenkins IH, et al. Tremor associated with benign IgM paraproteinaemic neuropathy. Brain 1996;119:789-99.
42. Yeung KB, Thomas PK, King RH, et al. The clinical spectrum of peripheral neuropathies associated with benign monocloncal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings. J Neurol 1991;238:383-91.
43. Planté-Bordeneuve V, Guiochon-Mantel A, Lacroix C, et al. The Roussy-Lévy family: from the original description to the gene. Ann Neurol 1999;46:770-3.
44. Seidel S, Kasprian G, Leutmezer F, et al. Disruption of nigrostriatal and cerebellothalamic pathways in dopamine responsive Holmes' tremor. J Neurol Neurosurg Psychiatry 2009;80:921-3.
45. McManis PG, Sharbrough FW. Orthostatic tremor: clinical and electrophysiologic characteristics. Muscle Nerve 1993;16:1254-60.
46. Gerschlager W, Münchau A, Katzenschlager R, et al. Natural history and syndromic assocations of orthostatic tremor: a review of 41 patients. Mov Disord 2004;19:788-95.
47. Berry-Kravis W, Abrams L, Coffey SM, et al. Fragile X-associated tremor/ataxia syndrome: clinical features, genetics and testing guidelines. Mov Disord 2007;22:2018-30.
48. Machado A, Chien HF, Deguti MM, et al. Neurological manifestations in Wilson's disease: Report of 119 cases. Mov Disord 2006;21:2192-6.